Fludarabine-based conditioning used in successful bone marrow transplantation from an unrelated donor in a heavily transfused patient with severe aplastic anemia.
Abe
Yasunobu
Y
Matsushima
Takamitsu
T
Tachikawa
Yoshimichi
Y
Nagasawa
Eriko
E
Nishimura
Junji
J
Nawata
Hajime
H
Muta
Koichiro
K
D000293:Adolescent; D000741:Anemia, Aplastic / Q000628:therapy*; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D012720:Severity of Illness Index; D014019:Tissue Donors; D019172:Transplantation Conditioning; D014740:Vidarabine / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D007166:Immunosuppressive Agents; D014740:Vidarabine; C024352:fludarabine
Blood. 2002 Aug 1;100(3):799-803
12130489
Int J Hematol. 2002 Feb;75(2):141-6
11939259
Blood. 2001 Dec 15;98(13):3595-9
11739162
Bone Marrow Transplant. 2001 Oct;28(8):783-5
11781631
Bone Marrow Transplant. 2001 Jan;27(2):125-8
11281379
Blood. 1998 Feb 1;91(3):756-63
9446633
Biol Blood Marrow Transplant. 2001;7(4):208-15
11349807
Blood. 2001 Jun 1;97(11):3390-400
11369628